The global prevalence of primary immunodeficiency is rising, giving impetus to the global intravenous immunoglobulins market. A report is published by Fortune Business Insights, titled “Intravenous Immunoglobulins: Global Market Analysis, Insights and Forecast, 2018-2025,” offers in-depth insights into the market. As per the report, in 2017 the global market was worth US$ 9,787.6 Mn. The market is anticipated to further expand at a CAGR of 6.2% and reach US$ 15,789.1 by the end of 2025.
 
In terms of indication, the report classifies the global market in primary immunodeficiency, chronic inflammatory demyelinating polyneuropathy (CIDP), and others. Primary immunodeficiency was leading the market in 2017. The segment accounted for 28.6% of the global market in 2017. During the forecast period 2018-2025, the segment is likely to witness expansion at an impressive pace. Diagnosis of primary immunodeficiency is gaining momentum and encouraging the adoption of intravenous immunoglobulins. Moreover, patients who are incapable to perform self-intervention of  immunoglobulin are further generating high demand in the intravenous immunoglobulins market. Besides this, the chronic inflammatory demyelinating polyneuropathy segment is forecast to show a slower growth owing to the low prevalence of the disease the segment may witness slow growth.

Get Sample PDF Brochure: 
https://www.fortunebusinessinsights.com/enquiry/sample/intravenous-immunoglobulins-market-100593
 
 
Intravenous Immunoglobulin Application in Hospitals to Rise Persistently
 
Intravenous immunoglobulin is the most common route of administration of immunoglobulins, which is the chief driver of the global market. The rising demand from hospitals and specialty clinics is anticipated to encourage the adoption of intravenous immunoglobulins. Furthermore, key companies are increasingly investing in research and development of advanced intravenous immunoglobulins. Such researches are likely to enable growth in the market over the forecast period.
 
Immunoglobulins are proven to be one of the best treatment options for various immune diseases. Owing to the high popularity of immunoglobulins, the market is foreseen to witness high demand.
 
On the contrary, factors that may restrain the global intravenous immunoglobulins market are side effects associated with intravenous immunoglobulins and intravenous immunoglobulin’s high cost.
 
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit:https://www.fortunebusinessinsights.com/industry-reports/intravenous-immunoglobulins-market-100593